Analysis of Long Noncoding RNA ZNF667-AS1 as a Potential Biomarker for Diagnosis and Prognosis of Glioma Patients

<div>ZNF667-AS1 may be a potential diagnostic biomarker for glioma patients. (a) The ROC curve for the diagnostic value of ZNF667-AS1 in distinguishing glioma specimens from nontumor brain specimens. (b) The ROC curve for the diagnostic value of ZNF667-AS1 in distinguishing glioma specimens with stages (I-II) from glioma specimens with stages (III-IV).</div>

Disease Markers

fig3

Figure 3

Figure 3: Analysis of Long Noncoding RNA ZNF667-AS1 as a Potential Biomarker for Diagnosis and Prognosis of Glioma Patients 